Daxor Corporation to Exhibit at the Society for Critical Care Medicine 49th Congress
12 févr. 2020 08h00 HE
|
Daxor Corporation
New Data Scheduled for Presentation on Daxor’s BVA-100® NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation...
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019
12 nov. 2019 08h00 HE
|
Daxor Corporation
NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest
06 août 2019 08h00 HE
|
Daxor Corporation
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
21 mars 2019 08h30 HE
|
Daxor Corporation
Author incorrectly claimed, “The company's sole product is a blood volume analyzer called the BVA-100 but there does not appear to be any sales to date.” NEW YORK, March 21, 2019 (GLOBE NEWSWIRE)...
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
15 mars 2019 08h30 HE
|
Daxor Corporation
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
New Data Demonstrating the Clinical Utility of Daxor’s BVA-100 in Hypertension Management to be Presented at the American Heart Association’s Scientific Sessions 2018
08 nov. 2018 13h46 HE
|
Daxor Corporation
Daxor to Exhibit at American Heart Association 2018 NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation...
New Independent Data Further Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) Over Surrogate Measurements
17 sept. 2018 08h30 HE
|
Daxor Corporation
NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
A New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use
19 avr. 2018 09h00 HE
|
Daxor Corporation
New York, NY, April 19, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces the publication of new...
Daxor to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
05 avr. 2018 09h00 HE
|
Daxor Corporation
New York, NY, April 05, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will present at...
Daxor to Exhibit at the American Association of Heart Failure Nurses 2018 Advanced Heart Failure Symposium
22 mars 2018 09h00 HE
|
Daxor Corporation
New York, NY, March 22, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will exhibit for the...